These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 6517086)

  • 21. Cost containment of reconstituted parenteral antibiotics: personnel and supply costs associated with preparation, dispensing, and administration.
    Tanner DJ
    Rev Infect Dis; 1984; 6 Suppl 4():S924-37. PubMed ID: 6522928
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potential for nonnarcotic analgesics to save personnel costs associated with controlling injectable morphine and meperidine.
    Koffer H; Hildebrand JR; Connell ML
    Am J Hosp Pharm; 1990 May; 47(5):1084-8. PubMed ID: 2337099
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stability and cost analysis of clindamycin-gentamicin admixtures given every eight hours.
    Mansur JM; Abramowitz PW; Lerner SA; Smith RB; Townsend RJ
    Am J Hosp Pharm; 1985 Feb; 42(2):332-5. PubMed ID: 3976680
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Economics of providing antineoplastic drugs in a manufacturer-mixed bulk package.
    Kleinberg ML; Duafala ME
    Am J Hosp Pharm; 1988 Jan; 45(1):109-15. PubMed ID: 3348222
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Premixed intravenous admixtures: a positive development for hospital pharmacy.
    Lee HE
    Am J Hosp Pharm; 1983 Jun; 40(6):1043-4. PubMed ID: 6869393
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost comparison of seven antibiotic combinations as empiric therapy in a simulated febrile neutropenic patient.
    Parr MD; Waite WW; Hansen LA; McDaniel PA
    Am J Hosp Pharm; 1985 Nov; 42(11):2484-8. PubMed ID: 4073066
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative analysis of drug distribution costs for controlled versus noncontrolled oral analgesics.
    Reynolds RC; Ploetz P; Thielke TS
    Am J Hosp Pharm; 1984 Aug; 41(8):1558-63. PubMed ID: 6475974
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of six methods for preparing cefazolin sodium for intermittent injection.
    Markowsky SJ; Kitrenos JG
    Am J Hosp Pharm; 1983 Oct; 40(10):1653-8. PubMed ID: 6638027
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of gentamicin premixed admixtures: cost and clinical utility.
    Zarowitz BJ; Owen H; Popovich J; Pancorbo S
    Hosp Pharm; 1987 Mar; 22(3):257-60. PubMed ID: 10311980
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost comparison of intravenous antibiotic administration.
    Plumridge RJ
    Med J Aust; 1990 Nov; 153(9):516-8. PubMed ID: 2233472
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Time and cost comparison of four methods of filling drug manufacturers' piggyback bottles.
    Anderson ER; Soares MS
    Am J Hosp Pharm; 1985 May; 42(5):1083-6. PubMed ID: 4003420
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Financial assessment of device for the preparation of intravenous mixtures in hospital pharmacy].
    Casado Collado A; Luengo Pascual L; Herdman M; Bonafont Pujol X; Clemente Bautista S; Jódar Masanés R; Napal Lecumberri V; Serrano Padilla G
    Farm Hosp; 2004; 28(4):243-50. PubMed ID: 15369434
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Syringes versus minibags as an intravenous admixture system: a comparison of cost and nursing preference.
    Gin A; Martens D; Dobson K; Hall K
    Can J Hosp Pharm; 1987 Jun; 40(3):81-5. PubMed ID: 10282581
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacy component of a hospital end-product cost-accounting system.
    Smith JE; Sheaffer SL; Meyer GE; Giorgilli F
    Am J Hosp Pharm; 1988 Apr; 45(4):835-43. PubMed ID: 3376968
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Two methods for allocating pharmacy cost per patient case.
    Pink GH; Bolley HB; Cockerill RW
    Am J Hosp Pharm; 1994 May; 51(10):1331-4. PubMed ID: 8085571
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost savings achieved through cephalosporin use review and restriction.
    Dzierba SH; Reilly RT; Caselnova DA
    Am J Hosp Pharm; 1986 Sep; 43(9):2194-7. PubMed ID: 3766571
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Economic assessment of different administration modes for total parenteral nutrition].
    Achach K; Peroux E; Hébuterne X
    Gastroenterol Clin Biol; 2002; 26(8-9):680-5. PubMed ID: 12434068
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An analysis of potential and real cost savings by the addition of ranitidine to total parenteral nutrition solutions.
    Pearson VE; King LM
    Hosp Pharm; 1992 Jul; 27(7):610, 613-4. PubMed ID: 10119189
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Veterans Administration medical center policies and procedures for handling injectable antineoplastic drugs.
    Moody DG
    Am J Hosp Pharm; 1984 May; 41(5):916-9. PubMed ID: 6731452
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outsourcing inpatient i.v. compounding: expense and medication error implications.
    Burruss RA; Carroll NV; Schraa C; Burton B
    Pharm Pract Manag Q; 1996 Oct; 16(3):52-9. PubMed ID: 10166235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.